GEP201706749B - Vortioxetine manufacturing process - Google Patents

Vortioxetine manufacturing process

Info

Publication number
GEP201706749B
GEP201706749B GEAP201413919A GEAP2014013919A GEP201706749B GE P201706749 B GEP201706749 B GE P201706749B GE AP201413919 A GEAP201413919 A GE AP201413919A GE AP2014013919 A GEAP2014013919 A GE AP2014013919A GE P201706749 B GEP201706749 B GE P201706749B
Authority
GE
Georgia
Prior art keywords
vortioxetine
manufacturing process
dimethyl
decomplexation
thiophenolate
Prior art date
Application number
GEAP201413919A
Other languages
English (en)
Inventor
Thomas Ruhland
Kim Lasse Christensen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of GEP201706749B publication Critical patent/GEP201706749B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
GEAP201413919A 2013-02-22 2014-02-20 Vortioxetine manufacturing process GEP201706749B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA201300104 2013-02-22

Publications (1)

Publication Number Publication Date
GEP201706749B true GEP201706749B (en) 2017-10-10

Family

ID=59215387

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP201413919A GEP201706749B (en) 2013-02-22 2014-02-20 Vortioxetine manufacturing process

Country Status (37)

Country Link
US (1) US9353073B2 (enExample)
EP (1) EP2958903B1 (enExample)
JP (1) JP6464098B2 (enExample)
KR (1) KR102230628B1 (enExample)
CN (1) CN104995181B (enExample)
AP (1) AP2015008640A0 (enExample)
AU (1) AU2014220735B2 (enExample)
BR (1) BR112015019268B1 (enExample)
CA (1) CA2901821A1 (enExample)
CL (1) CL2015002309A1 (enExample)
CR (1) CR20150423A (enExample)
CY (1) CY1118883T1 (enExample)
DK (1) DK2958903T3 (enExample)
DO (1) DOP2015000187A (enExample)
EA (1) EA027756B1 (enExample)
ES (1) ES2625380T3 (enExample)
GE (1) GEP201706749B (enExample)
HR (1) HRP20170607T1 (enExample)
IL (1) IL240501B (enExample)
LT (1) LT2958903T (enExample)
MA (1) MA38338B1 (enExample)
ME (1) ME02671B (enExample)
MX (1) MX362355B (enExample)
MY (1) MY172337A (enExample)
PE (1) PE20151589A1 (enExample)
PH (1) PH12015501807B1 (enExample)
PL (1) PL2958903T3 (enExample)
PT (1) PT2958903T (enExample)
RS (1) RS55932B1 (enExample)
RU (1) RU2652265C2 (enExample)
SG (1) SG11201506651SA (enExample)
SI (1) SI2958903T1 (enExample)
SM (1) SMT201700238T1 (enExample)
TN (1) TN2015000335A1 (enExample)
UA (1) UA116236C2 (enExample)
WO (1) WO2014128207A1 (enExample)
ZA (1) ZA201506050B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2605652B1 (en) 2010-08-18 2017-11-08 Samumed, LLC Diketones and hydroxyketones as catenin signaling pathway activators
ES2709824T3 (es) 2013-02-22 2019-04-17 Samumed Llc Gamma-dicetonas como activadores de la ruta de señalización Wnt/beta-catenina
DK3206686T3 (da) 2014-08-20 2019-12-16 Samumed Llc Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker
WO2016125191A2 (en) 2015-02-04 2016-08-11 Mylan Laboratories Limited Processes for the preparation of vortioxetine hydrobromide
EP3274330A1 (en) 2015-03-26 2018-01-31 Cipla Limited Method for making serotonin reuptake inhibitors
CN106279065A (zh) * 2015-05-12 2017-01-04 北京深蓝海生物医药科技有限公司 一种氢溴酸沃替西汀的精制转晶方法
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
EP3414216B1 (en) * 2016-02-08 2020-10-21 AAA Chemistry ApS Arylation of aliphatic amines
JP2019524682A (ja) 2016-07-01 2019-09-05 ハー・ルンドベック・アクチエゼルスカベット 抗うつ作用の速い発現のためのボルチオキセチン投与計画
US10519121B2 (en) 2016-12-30 2019-12-31 Apicore Us Llc Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
EP3870292A4 (en) 2018-10-26 2022-11-09 The Research Foundation for The State University of New York COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA
CN109912538B (zh) * 2019-01-22 2021-03-12 安徽赛乐普制药有限公司 一种抗抑郁药沃替西汀的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
MXPA04005989A (es) * 2001-12-20 2004-09-27 Lundbeck & Co As H Derivados de ariloxifenilo y arilsulfanilfenilo.
KR20090028712A (ko) * 2006-06-16 2009-03-19 하. 룬트벡 아크티에 셀스카브 인지기능 장애의 치료를 위한, 세로토닌 재흡수, 5-ht3 및 5-ht1a 활성이 조합된 화합물로서의 1-[2-(2,4-디메틸페닐술파닐)-페닐]피페라진
TW201033181A (en) * 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine

Also Published As

Publication number Publication date
RU2015134407A (ru) 2017-03-28
IL240501B (en) 2018-08-30
IL240501A0 (en) 2015-09-24
EA201591349A1 (ru) 2015-12-30
PE20151589A1 (es) 2015-12-03
PL2958903T3 (pl) 2017-08-31
RU2652265C2 (ru) 2018-04-27
WO2014128207A1 (en) 2014-08-28
SMT201700238T1 (it) 2017-07-18
MX362355B (es) 2019-01-14
HK1216098A1 (en) 2016-10-14
CL2015002309A1 (es) 2016-03-04
CR20150423A (es) 2015-10-20
US20160009670A1 (en) 2016-01-14
ES2625380T3 (es) 2017-07-19
CN104995181B (zh) 2017-03-08
PH12015501807B1 (en) 2019-05-31
MY172337A (en) 2019-11-21
US9353073B2 (en) 2016-05-31
EP2958903A1 (en) 2015-12-30
ME02671B (me) 2017-06-20
JP2016509042A (ja) 2016-03-24
BR112015019268B1 (pt) 2023-01-10
LT2958903T (lt) 2017-08-25
MX2015010656A (es) 2015-12-17
AU2014220735A1 (en) 2015-08-20
DOP2015000187A (es) 2015-11-30
HRP20170607T1 (hr) 2017-06-30
EA027756B1 (ru) 2017-08-31
PT2958903T (pt) 2017-05-26
RS55932B1 (sr) 2017-09-29
AP2015008640A0 (en) 2015-08-31
CN104995181A (zh) 2015-10-21
EP2958903B1 (en) 2017-04-12
DK2958903T3 (en) 2017-05-15
MA38338A1 (fr) 2016-09-30
KR20150118146A (ko) 2015-10-21
TN2015000335A1 (en) 2017-01-03
SI2958903T1 (sl) 2017-09-29
SG11201506651SA (en) 2015-09-29
JP6464098B2 (ja) 2019-02-06
MA38338B1 (fr) 2018-10-31
AU2014220735B2 (en) 2017-06-22
CY1118883T1 (el) 2018-01-10
BR112015019268A2 (pt) 2020-01-28
KR102230628B1 (ko) 2021-03-22
UA116236C2 (uk) 2018-02-26
ZA201506050B (en) 2017-08-30
CA2901821A1 (en) 2014-08-28
PH12015501807A1 (en) 2015-11-09

Similar Documents

Publication Publication Date Title
GEP201706749B (en) Vortioxetine manufacturing process
IN2014MN02496A (enExample)
GEP20217223B (en) Prodrugs of pyridone amides useful as modulators of sodium channels
NZ711326A (en) A process for sodium salt of (2s, 5r)-2-carboxamido-7-oxo-6-sulfooxy -1,6-diaza-bicyclo[3.2.1]octane
MX2015011438A (es) Procedimiento para preparar compuestos benzoxazepina.
NZ711343A (en) Sodium salt of (2s, 5r)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation
IN2014DN00144A (enExample)
BR112015029399A2 (pt) produção em etapa única de uma composição de polipropileno
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
MX2016007340A (es) Formulacion de biomasa.
WO2014087208A3 (en) A process of preparing alcaftadine
MY174153A (en) Processes for the preparation of pyrimidinylcyclopentane compounds
EA201691074A1 (ru) Синтез энт-прогестерона и его промежуточных соединений
MX2016006807A (es) Derivados de imidazol.
EA201590594A1 (ru) Макролидные производные, их получение и их терапевтическое использование
EA027831B9 (ru) СПОСОБ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНЫХ СОСТОЯНИЙ С ПРИМЕНЕНИЕМ S-[4-(3-ФТОР-3-МЕТИЛБУТИРИЛОКСИ)БУТ-2-ИНИЛ]6α,9α-ДИФТОР-17α-(ФУРАН-2-ИЛ)КАРБОНИЛОКСИ-11β-ГИДРОКСИ-16α-МЕТИЛ-3-ОКСОАНДРОСТА-1,4-ДИЕН-17β-КАРБОТИОАТА
EA201490019A1 (ru) Способ получения производных имидазола
PH12015501840A1 (en) Production method of pyridazinone compounds
IN2013MU03909A (enExample)
MX2014012822A (es) Proceso para elaborar derivados de naftiridina.
MX2015017747A (es) Proceso para producir 2-fenil-1, 3-benzoxazoles.
IN2014DN07498A (enExample)
MX361673B (es) Procedimiento para la preparación de intermediarios de ácido borónico.
MY161361A (en) Substituted phenyl compounds
BR112015017326A2 (pt) processo para a produção de 2-alquil-3-butin-2-óis